ZA200903125B - Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs - Google Patents

Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Info

Publication number
ZA200903125B
ZA200903125B ZA200903125A ZA200903125A ZA200903125B ZA 200903125 B ZA200903125 B ZA 200903125B ZA 200903125 A ZA200903125 A ZA 200903125A ZA 200903125 A ZA200903125 A ZA 200903125A ZA 200903125 B ZA200903125 B ZA 200903125B
Authority
ZA
South Africa
Prior art keywords
self
application
cancer drugs
nanoparticles composed
specific intra
Prior art date
Application number
ZA200903125A
Other languages
English (en)
Inventor
Nadya I Tarasova
Sergey G Tarasov
Christopher J Michejda
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Publication of ZA200903125B publication Critical patent/ZA200903125B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200903125A 2006-11-07 2009-05-06 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs ZA200903125B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86466506P 2006-11-07 2006-11-07

Publications (1)

Publication Number Publication Date
ZA200903125B true ZA200903125B (en) 2010-05-26

Family

ID=39365311

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903125A ZA200903125B (en) 2006-11-07 2009-05-06 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Country Status (9)

Country Link
US (1) US9326950B2 (enExample)
EP (1) EP2086521A2 (enExample)
JP (1) JP2010509241A (enExample)
CN (1) CN101610759A (enExample)
AU (1) AU2007316416A1 (enExample)
CA (1) CA2668638A1 (enExample)
NZ (1) NZ576769A (enExample)
WO (1) WO2008058125A2 (enExample)
ZA (1) ZA200903125B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ576769A (en) * 2006-11-07 2012-01-12 Us Gov Health & Human Serv Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
WO2012162628A2 (en) 2011-05-25 2012-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of ras oncoproteins
EP2911701A4 (en) 2012-10-23 2016-06-08 Univ Johns Hopkins Novel self-assembling drug amphiphiles and methods for synthesis and application
ES2625024B1 (es) * 2015-12-18 2018-05-10 Consejo Superior De Investigaciones Cientificas Material que comprende tectómeros de oligoglicina y nanohilos
US11246924B2 (en) 2016-04-01 2022-02-15 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US20220387605A1 (en) * 2017-07-18 2022-12-08 Duke University Compositions and methods comprising self-assembling peptide-polymer nanofibers for sublingual immunization

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211471T1 (de) 1996-04-12 2002-01-15 Us Gov Health & Human Serv Acridonderivate als antineoplastische-und antiretrovirale mittel
WO1999043711A1 (en) 1998-02-27 1999-09-02 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services G protein-coupled receptor antagonists
US7105488B1 (en) 1998-02-27 2006-09-12 The United States Of America As Represented By The Department Of Health And Human Services G protein-coupled receptor antagonists
US7517849B1 (en) * 1999-11-18 2009-04-14 The United States Of America As Represented By The Secretary Of Health And Human Services Inhibition of ABC transporters by transmembrane domain analogs
ATE250603T1 (de) 2000-03-07 2003-10-15 Us Gov Health & Human Serv 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung
CN1254234C (zh) * 2000-06-09 2006-05-03 莱古伦公司 质粒dna(lipogenestm)和含细胞核定位信号/促融合肽缀合物的治疗剂包封到定向脂质体复合体中
AU2002240201A1 (en) * 2001-02-02 2002-08-19 Yale University Peptides for facilitating composite receptor expression and translocation of macromolecules
US20070009441A1 (en) * 2004-07-08 2007-01-11 Molecular Therapeutics, Inc. Biodegradable nanoparticles
NZ576769A (en) * 2006-11-07 2012-01-12 Us Gov Health & Human Serv Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Also Published As

Publication number Publication date
WO2008058125A2 (en) 2008-05-15
JP2010509241A (ja) 2010-03-25
EP2086521A2 (en) 2009-08-12
CN101610759A (zh) 2009-12-23
CA2668638A1 (en) 2008-05-15
NZ576769A (en) 2012-01-12
WO2008058125A3 (en) 2008-10-16
AU2007316416A1 (en) 2008-05-15
US9326950B2 (en) 2016-05-03
US20100034896A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
EP2464224A4 (en) METHOD FOR THE ADMINISTRATIVE ADMINISTRATION WITH UNFOLDED AND FOLDED PROTEINS AND PEPTID NANOPARTICLES
ZA200903125B (en) Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
IL192869A0 (en) Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
IL200857A (en) Tubolysin conjugates to transfer ligand-associated drugs
EP1833470A4 (en) NANOPARTICLES FOR PROTEIN SUBSTANCE DELIVERY
IL210883A0 (en) Drug delivery system and method of munufacturing thereof
DK2567707T3 (en) Composition of tumour-associated peptides and related anti-cancer vaccine
EP2013016B8 (en) Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
IL213376A0 (en) Zaleplon gastroretentive drug delivery system and uses thereof
EP2162283A4 (en) SELF-BUILDING FILMS FOR PROTEIN AND DRUG DELIVERY APPLICATIONS
IL199041A (en) We nanoparticle peptides and their uses
EP2400851A4 (en) COMPOSITION AND ACTIVE COMPOSITION OF BISPHOSPHONATES
HUE046071T2 (hu) Eljárások és készítmények gyógyszerek elnyújtott hatóanyagleadására
IL209419A0 (en) Modified drugs for use in liposomal nanoparticles
EP2091914A4 (en) TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
EP2164631A4 (en) MODIFICATION OF DRUG RELIEF IN SUSPENSIONS OF IONIC RESIN SYSTEMS
ZA201104497B (en) Peptide therapeutic conjugates and uses thereof
EP2413917A4 (en) DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
IL213855A0 (en) Electronic control of drug delivery system
EP2247311A4 (en) COMPOSITIONS FOR RELEASING CARGO SUCH AS MEDICINES, PROTEINS AND / OR MATERIAL GENETIC SUBSTANCES
IL227737A0 (en) A substance for drug delivery capable of passing through the blood-brain barrier, and a peptide and its use
PL2338473T3 (pl) Postacie farmaceutycznej dawki tizanidyny i drogi jej podawania
PL381925A1 (pl) Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny
TWI350178B (en) Magnetic nanoparticles for targeted hydrophobic drug delivery and their production method and application